Macrogenics News

Macrogenics Analyst Ratings

BenzingaMay 13 12:23 ET

Hold Rating on MacroGenics Amid Safety and Efficacy Concerns for Vobra Duo

TipRanksMay 13 06:26 ET

Macrogenics Analyst Ratings

BenzingaMay 10 12:52 ET

Macrogenics Analyst Ratings

BenzingaMay 10 05:37 ET

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), Insmed (INSM) and MacroGenics (MGNX)

TipRanksMay 10 05:20 ET

Buy Rating on MacroGenics: Promising Clinical Data and Market Position in MCRPC Treatment

TipRanksMay 10 01:06 ET

Hold Rating on MacroGenics Amid TAMARACK Study Results and Competitive Concerns

TipRanksMay 9 22:05 ET

B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target

MT NewswiresApr 26 08:00 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Enlivex (ENLV), MacroGenics (MGNX) and Immuneering (IMRX)

TipRanksApr 12 06:30 ET

Macrogenics Analyst Ratings

BenzingaApr 9 06:36 ET

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and MacroGenics (MGNX)

TipRanksApr 8 04:00 ET

Macrogenics Analyst Ratings

BenzingaApr 4 08:54 ET

Buy Rating Affirmed for MacroGenics on Strong Safety Profile and Anticipated Efficacy Data

TipRanksApr 4 07:16 ET

Barclays Sticks to Its Buy Rating for MacroGenics (MGNX)

TipRanksApr 4 04:35 ET

Positive Outlook for MacroGenics: Buy Rating Affirmed Amid Vobra-duo Developments

TipRanksApr 3 19:25 ET

Macrogenics Analyst Ratings

BenzingaMar 11 06:41 ET

Buy Rating Affirmed for MacroGenics on Promising Pipeline and Strong Financials

TipRanksMar 11 00:45 ET

Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)

TipRanksMar 10 17:31 ET

Macrogenics Analyst Ratings

BenzingaMar 8 06:04 ET

MacroGenics (MGNX) Receives a Buy From Barclays

TipRanksMar 8 03:46 ET